Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001646162-15-000001
Filing Date
2015-08-04
Accepted
2015-08-04 14:52:39
Documents
1
Effectiveness Date
2015-08-04
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6723
  Complete submission text file 0001646162-15-000001.txt   7813
Mailing Address 11099 N. TORREY PINES ROAD SUITE 290 LA JOLLA CA 92037
Business Address 11099 N. TORREY PINES ROAD SUITE 290 LA JOLLA CA 92037 858 750 4739
Ankasa Regenerative Therapeutics, Inc. (Filer) CIK: 0001646162 (see all company filings)

EIN.: 471928158 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-245063 | Film No.: 151025100